Molecular Cochaperones: Tumor Growth and Cancer Treatment
Author(s) -
Stuart K. Calderwood
Publication year - 2013
Publication title -
scientifica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.474
H-Index - 21
ISSN - 2090-908X
DOI - 10.1155/2013/217513
Subject(s) - hsp90 , heat shock protein , co chaperone , biology , chaperone (clinical) , proteome , cdc37 , cancer research , cancer , phenotype , computational biology , bioinformatics , microbiology and biotechnology , genetics , medicine , gene , pathology
Molecular chaperones play important roles in all cellular organisms by maintaining the proteome in an optimally folded state. They appear to be at a premium in cancer cells whose evolution along the malignant pathways requires the fostering of cohorts of mutant proteins that are employed to overcome tumor suppressive regulation. To function at significant rates in cells, HSPs interact with cochaperones, proteins that assist in catalyzing individual steps in molecular chaperoning as well as in posttranslational modification and intracellular localization. We review current knowledge regarding the roles of chaperones such as heat shock protein 90 (Hsp90) and Hsp70 and their cochaperones in cancer. Cochaperones are potential targets for cancer therapy in themselves and can be used to assess the likely prognosis of individual malignancies. Hsp70 cochaperones Bag1, Bag3, and Hop play significant roles in the etiology of some cancers as do Hsp90 cochaperones Aha1, p23, Cdc37, and FKBP1. Others such as the J domain protein family, HspBP1, TTC4, and FKBPL appear to be associated with more benign tumor phenotypes. The key importance of cochaperones for many pathways of protein folding in cancer suggests high promise for the future development of novel pharmaceutical agents.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom